Superselective Adrenal Arterial Embolization for Refractory Hypertension: A Proof-of-Concept Study
The subjects of this study were patients with essential refractory hypertension. The purpose of this study is to evaluate the safety and efficacy of superselective adrenal arterial embolization (SAAE) in patients with primary refractory hypertension and to explore the possibility of SAAE in patients with primary refractory hypertension.After the subject completes the SAAE, an 8-week follow-up will be conducted to assess the safety and effectiveness of the SAAE.
Conditions studied
Essential Hypertension
About this study
The subjects of this study were patients with essential refractory hypertension. The purpose of this study is to evaluate the safety and efficacy of superselective adrenal arterial embolization (SAAE) in patients with primary refractory hypertension and to explore the possibility of SAAE in patients with primary refractory hypertension.After the subject completes the SAAE, an 8-week follow-up will be conducted to assess the safety and effectiveness of the SAAE.
Interventions
- Procedure: Superselective adrenal arterial embolization — Superselective adrenal arterial embolization is an operation to inject embolic agent into adrenal artery through catheter to embolize part of adrenal gland, so as to reduce the secretion of adrenal hormone and reduce blood pressure.
Primary outcomes
- 24-hour mean systolic blood pressure (8 weeks after SAAE)
Eligibility information
Study locations
- The Second Affiliated Hospital of Nanchang University, Nanchang, China
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.